ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,725, issued on June 3, was assigned to HAINAN SIMCERE PHARMACEUTICAL Co. LTD. (Haikou, China).

"IL-2 mutant and application thereof" was invented by Yingying Hu (Shanghai), Zhuoxiao Cao (Shanghai), Renhong Tang (Jiangsu, China), Hu Ge (Shangai, China), Yayuan Fu (Shanghai) and Jinsheng Ren (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure discloses IL-2 mutants and uses thereof. More specifically, the disclosure provides IL-2 mutants and corresponding fusion proteins, conjugates, nucleic acid fragments, vectors, host cells, methods for preparing the mutants or fusion proteins, IL-2 mutants or fusion proteins prepar...